A team of surgeons from various medical specialties, including neurology, neurosurgery, critical care, and ICU, successfully ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Anavex Life Sciences (AVXL – Research Report) today and set a price target of ...

Acadia is on track to achieve over $1 billion in annualized sales in 2025. The next phase of growth could come from two ...

The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer ... and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid ...

Parkinson’s disease is a brain disorder that affects about one million people in the U.S. It happens when the brain loses ...

Earlier this month, I was also pleased to attend the 120th anniversary of the St. Nicholas Ukrainian Church at 6594 Henderson ...

The global neurostimulation devices market size was US$4.7 billion in 2019. The global neurostimulation devices market is forecast to reach the value of US$14.5 billion by 2030 by registering a ...

Nuclear Medicine Market OverviewThe global nuclear medicine market is poised to experience substantial growth, projected to ...

Research unveils the complex relationship between dopamine and serotonin, transforming our understanding of brain chemistry ...

DOVER, DE, USA I6, 2024 I Brenig Therapeutics announced the initiation of the first-in-human clinical trial for BT-267, a best-in-class LRRK2 ...

Previous research has discovered a possible link between distressing dreams and a higher risk of dementia in people with ...

Alector has significant cash reserves but faces high cash burn, with no immediate catalysts and uncertain prospects for its ...